Research output per year
Research output per year
Fingerprint
Dive into the research topics where Christopher Ryan is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
A phase II trial of regorafenib in patients with advanced Ewing sarcoma and related tumors of soft tissue and bone: SARC024 trial results
Attia, S., Bolejack, V., Ganjoo, K. N., George, S., Agulnik, M., Rushing, D., Loggers, E. T., Livingston, M. B., Wright, J., Chawla, S. P., Okuno, S. H., Reinke, D. K., Riedel, R. F., Davis, L. E., Ryan, C. W. & Maki, R. G., Jan 2023, In: Cancer medicine. 12, 2, p. 1532-1539 8 p.Research output: Contribution to journal › Article › peer-review
Open Access5 Scopus citations -
A Phase II, Single-arm Trial of Sunitinib and Erlotinib in Advanced Renal Cell Carcinoma
Feng, Z., Curti, B. D., Quinn, D. I., Strother, J. M., Chen, Z., Agnor, R., Beer, T. M. & Ryan, C. W., Oct 2022, In: Clinical Genitourinary Cancer. 20, 5, p. 415-422 8 p.Research output: Contribution to journal › Article › peer-review
-
A Prospective Multicenter Evaluation of Initial Treatment Choice in Metastatic Renal Cell Carcinoma Prior to the Immunotherapy Era: The MaRCC Registry Experience
Costello, B. A., Bhavsar, N. A., Zakharia, Y., Pal, S. K., Vaishampayan, U., Jim, H., Fishman, M. N., Molina, A. M., Kyriakopoulos, C. E., Tsao, C. K., Appleman, L. J., Gartrell, B. A., Hussain, A., Stadler, W. M., Agarwal, N., Pachynski, R. K., Hutson, T. E., Hammers, H. J., Ryan, C. W., Mardekian, J., & 3 others, Feb 2022, In: Clinical Genitourinary Cancer. 20, 1, p. 1-10 10 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
A randomised phase II trial of a trivalent ganglioside vaccine targeting GM2, GD2 and GD3 combined with immunological adjuvant OPT-821 versus OPT-821 alone in metastatic sarcoma patients rendered disease-free by surgery
Rosenbaum, E., Chugh, R., Ryan, C. W., Agulnik, M., Milhem, M. M., George, S., Jones, R. L., Chmielowski, B., Van Tine, B. A., Tawbi, H., Elias, A. D., Read, W. L., Budd, G. T., Qin, L. X., Rodler, E. T., Hirman, J., Weiden, P., Bennett, C. M., Livingston, P. O., Ragupathi, G., & 6 others, Nov 2022, In: European Journal of Cancer. 176, p. 155-163 9 p.Research output: Contribution to journal › Article › peer-review
3 Scopus citations -
Selinexor in Advanced, Metastatic Dedifferentiated Liposarcoma: A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial
Gounder, M. M., Razak, A. A., Somaiah, N., Chawla, S., Martin-Broto, J., Grignani, G., Schuetze, S. M., Vincenzi, B., Wagner, A. J., Chmielowski, B., Jones, R. L., Riedel, R. F., Stacchiotti, S., Loggers, E. T., Ganjoo, K. N., Le Cesne, A., Italiano, A., Garcia Del Muro, X., Burgess, M., Piperno-Neumann, S., & 51 others, Aug 1 2022, In: Journal of Clinical Oncology. 40, 22, p. 2479-2490 12 p.Research output: Contribution to journal › Article › peer-review
Open Access11 Scopus citations